1 朱贵卿,主编,呼吸内科学[M].北京,人民卫生出版社,1984:626—623
2 穆魁津,何权瀛,主编,胸膜疾病[M].北京,北京医科大学中国协和医科大学联合出版社,1994,156—157
3 Light RW. Parapneumonic effusions and empyema [J]. Clin chest Med,1985,5:55-62
4 Light RW. Girard WM, Jenkinson SG, et al. Parapneumonic effusions [J]. Am Jmed,1980,69:507-512
5 刘昌起,主编,呼吸系统疾病治疗学[M].天渖,天津科学技术出版社,2000,685-689
6 陈继样,冯宪光.结核性渗出性胸膜炎的介入治疗[J].临床肺科杂志,2004,9(1):50
7 Moulton JS Moore PT, Mencini RA. Treatment of loculated pleural effusions with transcatheter intracavitary urokinase [J] . AJR 1989, 153:94-945
8 丁东,邓群益,张怀岭,等.胸膜腔内注入尿激酶预防结核性渗出性胸膜炎所致胸膜肥厚和包裹性积液的研究[J].中华结核和呼吸杂志,2001,24(1):32—34
9 Lee KS, Im JG, Kim YH, etal. Treatment of thoracic multiloculated empyemas wrth intracavitary urokinase: Aprospectives tud[J],Radioloyy ,1991,179—775
10 BorrosD, SchicaS, PatsourakisG, etal. Intrapleural sterpokinose versus Urokinasein the treatment of complicated Parapneumoric offuions: A prospective, double-blindstudy [J]. AmJ Respir Crit Care Med,1997,155:291—295
11 Pollak JS,Passik CS. Intrapleural urokinase in the treatment of loculated pleuraleffusions [J]. Chest, 1994,105:868 —873
|